NON ELECTRICAL USE OF RESIDUAL STEAM FROM THE LARDERELLO FIELD, ITALY.ALLEGRINI G.1976; GEO-HEAT UTILIZ. CENTER, QUART. BULL.; U.S.A.; DA. 1976; VOL. 2; NO 1; PP. 6-8Article

PRESENT STATUS AND NEW PROSPECTS OF GEOTHERMAL ENERGY IN ITALY = L'ENERGIE GEOTHERMIQUE EN ITALIE: SITUATION ACTUELLE ET NOUVELLES PERSPECTIVESALLEGRINI G; BURGASSI PD; SARTINI E et al.1981; TRANS. - GEOTHERM. RESOUR. COUNC.; ISSN 0193-5933; USA; DA. 1981; VOL. 5; PP. 1-4; BIBL. 6 REF.; 2 TAB. ; ILL.Conference Paper

Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinibBOCCI, G; FALCONE, A; DEL TACCA, M et al.British journal of cancer. 2008, Vol 98, Num 10, pp 1619-1629, issn 0007-0920, 11 p.Article

A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patientsALLEGRINI, G; FALCONE, A; DANESI, R et al.British journal of cancer. 2008, Vol 98, Num 8, pp 1312-1319, issn 0007-0920, 8 p.Article

Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5,6-dihydrouracil after conventional and reduced test dose in cancer patientsBOCCI, G; DANESI, R; DEL TACCA, M et al.Clinical cancer research. 2000, Vol 6, Num 8, pp 3032-3037, issn 1078-0432Article

Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy : a phase II studyFALCONE, A; ALLEGRINI, G; LENCIONI, M et al.Cancer chemotherapy and pharmacology. 1999, Vol 44, Num 2, pp 159-163, issn 0344-5704Article

First-line treatment of metastatic colorectal cancer with irinotecan, oxaliplatin and 5-fluorouracil/leucovorin (FOLFOXIRI): results of a phase II study with a simplified biweekly scheduleMASI, G; ALLEGRINI, G; CUPINI, S et al.Annals of oncology. 2004, Vol 15, Num 12, pp 1766-1772, issn 0923-7534, 7 p.Article

Relationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patientsDI PAOLO, A; DANESI, R; DEL TACCA, M et al.Annals of oncology. 2001, Vol 12, Num 9, pp 1301-1306, issn 0923-7534Article

Industrial uses of geothermal fluids at LarderelloALLEGRINI, G; LUCCIOLI, F; TRIVELLA, A et al.Geothermics. 1992, Vol 21, Num 5-6, pp 623-630, issn 0375-6505Conference Paper

First-line 5-fluorouracil/folinic acid, oxaliplatin and irinotecan (FOLFOXIRI) does not impair the feasibility and the activity of second line treatments in metastatic colorectal cancerMASI, G; MARCUCCI, L; CUPINI, S et al.Annals of oncology. 2006, Vol 17, Num 8, pp 1249-1254, issn 0923-7534, 6 p.Article

Severe 5-fluorouracil toxicity associated with a marked alteration of pharmacokinetics of 5-fluorouracil and its catabolite 5-fluoro-5,6-dihydrouracil: a case reportBOCCI, G; DANESI, R; ALLEGRINI, G et al.European journal of clinical pharmacology. 2002, Vol 58, Num 9, pp 593-595, issn 0031-6970, 3 p.Article

Infusions of fluorouracil and leucovorin : Effects of the timing and semi-intermittency of drug deliveryFALCONE, A; ALLEGRINI, G; ANTONUZZO, A et al.Oncology. 1999, Vol 57, Num 3, pp 195-201, issn 0030-2414Article

Suramin in combination with weekly epirubicin for patients with advanced hormone-refractory prostate carcinomaFALCONE, A; ANTONUZZO, A; DANESI, R et al.Cancer. 1999, Vol 86, Num 3, pp 470-476, issn 0008-543XArticle

Maximum tolerable doses of intravenous zidovudine in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer patients : Clinical evidence of significant antitumor activity and enhancement of zidovudine-induced DNA single strand breaks in peripheral nuclear blood cellsFALCONE, A; LENCIONI, M; CONTE, P. F et al.Annals of oncology. 1997, Vol 8, Num 6, pp 539-545, issn 0923-7534Article

Azidothymidine in combination with 5-fluorouracil in human colorectal cell lines : In vitro synergistic cytotoxicity and DNA-induced strand-breaksANDREUCCETTI, M; ALLEGRINI, G; ANTONUZZO, A et al.European journal of cancer (1990). 1996, Vol 32, Num 7, pp 1219-1226, issn 0959-8049Article